Effect of changes in skin properties due to diabetes mellitus on the titration period of transdermal fentanyl: single-center retrospective study and diabetic animal model study

Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev. 2006;32:304–15.

Article  CAS  PubMed  Google Scholar 

Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29:iv166-91.

Article  CAS  PubMed  Google Scholar 

Paice JA, Ferrell B. The management of cancer pain. CA Cancer J Clin. 2011;61:157–82.

Article  PubMed  Google Scholar 

Fiset P, Cohane C, Browne S, Brand SC, Shafer SL. Biopharmaceutics of a new transdermal fentanyl device. Anesthesiology. 1995;83:459–69.

Article  CAS  PubMed  Google Scholar 

Solassol I, Caumette L, Bressolle F, Garcia F, Thézenas S, Astre C, et al. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients. Oncol Rep. 2005;14:1029–36.

PubMed  Google Scholar 

Holdsworth MT, Forman WB, Killilea TA, Nystrom KM, Paul R, Brand SC, et al. Transdermal fentanyl disposition in elderly subjects. Gerontology. 1994;40:32–7.

Article  CAS  PubMed  Google Scholar 

Heiskanen T, Mätzke S, Haakana S, Gergov M, Vuori E, Kalso E. Transdermal fentanyl in cachectic cancer patients. Pain. 2009;144:218–22.

Article  CAS  PubMed  Google Scholar 

Nomura M, Inoue K, Matsushita S, Takahari D, Kondoh C, Shitara K, et al. Serum concentration of fentanyl during conversion from intravenous to transdermal administration to patients with chronic cancer pain. Clin J Pain. 2013;29:487–91.

Article  PubMed  Google Scholar 

Barratt DT, Bandak B, Klepstad P, Dale O, Kaasa S, Christrup LL, et al. Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. Pharmacogenet Genomics. 2014;24:185–94.

Article  CAS  PubMed  Google Scholar 

Kuip EJM, Zandvliet ML, Koolen SLW, Mathijssen RHJ, van der Rijt CCD. A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients. Br J Clin Pharmacol. 2017;83:294–313.

Article  CAS  PubMed  Google Scholar 

Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ. Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg. 1988;67:329–37.

Article  CAS  PubMed  Google Scholar 

Nakamura A, Hasegawa M, Ito H, Minami K, Koike K, Habu-Tomita N, et al. Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine, and fentanyl. J Pain Palliat Care Pharmacother. 2011;25:318–34.

Article  PubMed  Google Scholar 

McClain DA, Hug CC. Intravenous fentanyl kinetics. Clin Pharmacol Ther. 1980;28:106–14.

Article  CAS  PubMed  Google Scholar 

Kokubun H, Ebinuma K, Matoba M, Takayanagi R, Yamada Y, Yago K. Population pharmacokinetics of transdermal fentanyl in patients with cancer-related pain. J Pain Palliat Care Pharmacother. 2012;26:98–104.

Article  PubMed  Google Scholar 

Lane ME. The transdermal delivery of fentanyl. Eur J Pharm Biopharm. 2013;84:449–55.

Article  CAS  PubMed  Google Scholar 

Bista SR, Haywood A, Hardy J, Norris R, Hennig S. Exposure to Fentanyl After Transdermal Patch Administration for Cancer Pain Management. J Clin Pharmacol. 2016;56:705–13.

Article  CAS  PubMed  Google Scholar 

Peng PWH, Sandler AN. A Review of the Use of Fentanyl Analgesia in the Management of Acute Pain in Adults. Anesthesiology. 1999;90:576–99.

Article  CAS  PubMed  Google Scholar 

Kalia YN, Guy RH. Modeling transdermal drug release. Adv Drug Deliv Rev. 2001;48:159–72.

Article  CAS  PubMed  Google Scholar 

van Smeden J, Janssens M, Gooris GS, Bouwstra JA. The important role of stratum corneum lipids for the cutaneous barrier function. Biochim Biophys Acta Mol Cell Biol Lipids. 2014;1841:295–313.

Article  Google Scholar 

Koroukian SM, Murray P, Madigan E. Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol. 2006;24:2304–10.

Article  PubMed  Google Scholar 

Williams GR, Mackenzie A, Magnuson A, Olin R, Chapman A, Mohile S, et al. Comorbidity in older adults with cancer. J Geriatr Oncol. 2016;7:249–57.

Article  PubMed  Google Scholar 

Jalving M, Gietema JA, Lefrandt JD, de Jong S, Reyners AKL, Gans ROB, et al. Metformin: Taking away the candy for cancer? Eur J Cancer. 2010;46:2369–80.

Article  CAS  PubMed  Google Scholar 

Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and Cancer: A Consensus Report. CA Cancer J Clin. 2010;60:207–21.

Article  PubMed  Google Scholar 

Quondamatteo F. Skin and diabetes mellitus: What do we know? Cell Tissue Res. 2014;355:1–21.

Article  PubMed  Google Scholar 

Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366:1736–43.

Article  PubMed  Google Scholar 

Park H-Y, Kim J-H, Jung M, Chung CH, Hasham R, Park CS, et al. A long-standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process. Exp Dermatol. 2011;20:969–74.

Article  CAS  PubMed  Google Scholar 

Kim J, Yoon NY, Kim DH, Jung M, Jun M, Park H, et al. Impaired permeability and antimicrobial barriers in type 2 diabetes skin are linked to increased serum levels of advanced glycation end-product. Exp Dermatol. 2018;27:815–23.

Article  CAS  PubMed  Google Scholar 

Portenoy RK, Southam MA, Gupta SK, Lapin J, Layman M, Inturrisi CE, et al. Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics. Anesthesiology. 1993;78:36–43.

Article  CAS  PubMed  Google Scholar 

Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med. 1976;119:85–90.

Article  CAS  PubMed  Google Scholar 

Tsukui K, Suzuki M, Amma M, Tokudome Y. Ionic composition of Shotokuseki extract alters cell differentiation and lipid metabolism in three-dimensional cultured human epidermis. Cytotechnology. 2024;76:279–90.

Article  CAS  PubMed  Google Scholar 

Ishida T, Naito T, Sato H, Kawakami J. Relationship between the plasma fentanyl and serum 4β-hydroxycholesterol based on CYP3A5 genotype and gender in patients with cancer pain. Drug Metab Pharmacokinet. 2016;31:242–8.

Article  CAS  PubMed  Google Scholar 

Hisaka A, Sugiyama Y. Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference method. J Pharmacokinet Biopharm. 1998;26:495–519.

Article  CAS  PubMed  Google Scholar 

Man MQ, Wakefield JS, Mauro TM, Elias PM. Alterations in epidermal function in type 2 diabetes: Implications for the management of this disease. J Diabetes. 2022;14:586–95.

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif